세계의 Nplate 및 로미플레이트(로미플로스팀) 시장 보고서(2025년) : 역학, 파이프라인 분석, 시장 인사이트 및 예측

Nplate, Romiplate (romiplostim) Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

US $ 4,490 ￦ 6,310,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,121,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,932,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

Nplate 및 로미플레이트(로미플로스팀) 시장 규모는 향후 몇 년 동안 강력한 성장을 보일 것으로 예상됩니다. 예측 기간의 성장은 전 세계 의료 서비스의 접근성 향상, 건강 경제의 성장, 생명 공학 혁신의 증가, 효과적인 치료법의 증가, 혈액 질환의 증가에 기인할 수 있습니다. 예측 기간의 주요 동향으로는 신흥 바이오시밀러, 치료 프로토콜의 발전, 기술 통합, 의약품 전달 방식, 전략적 협력, 연구 개발에 대한 투자 등이 있습니다.

암 발병률의 증가는 Nplate 및 로미플레이트(로미플로스팀) 시장의 성장을 촉진할 것으로 예상됩니다. 암은 세포의 비정상적이고 통제되지 않은 증식을 특징으로 하는 질병을 의미합니다. 암 발병률의 증가는 인구 고령화, 발암 물질에 대한 환경적 노출, 건강에 해로운 생활 습관(예: 흡연, 잘못된 식습관), 유전적 요인, 그리고 암을 더 일찍, 더 자주 발견할 수 있게 하는 진단 기술의 발전 등 여러 요인에 기인합니다. Nplate 및 로미플레이트(로미플로스팀)는 혈소판 생성 수용체를 통해 혈소판 생성을 자극하여, 특히 화학요법을 받는 암 환자에게 혈소판 감소증(혈소판 수치 저하) 위험을 줄이고, 혈소판 수치를 개선하며, 치료 중 안전성을 높이고, 혈소판 수혈 필요성을 최소화하는 데 도움을 줍니다. 예를 들어, 2024년 8월 호주 보건 복지 연구소(Australian Institute of Health and Welfare)는 2034년까지 호주에서 약 20만 9,000건의 신규 암 진단 사례가 발생할 것으로 전망했으며, 이는 2024년 추정치인 16만 9,000건에서 증가한 수치로, 인구 증가와 암 발생률 상승의 영향을 반영합니다. 따라서 암 발병률의 증가는 Nplate 및 로미플레이트(로미플로스팀) 시장을 촉진할 것입니다.

의료비 지출의 증가는 Nplate 및 로미플레이트(로미플로스팀) 시장의 성장을 촉진할 것으로 예상됩니다. 의료비 지출은 개인 건강 관리, 예방 서비스, 건강 증진을 위한 공중 보건 활동 등 의료 상품 및 서비스에 대한 총 지출을 의미합니다. 의료비 지출의 증가는 인구 고령화, 만성 질환, 의료 기술의 발전, 의약품 가격 상승, 서비스 수요 증가 등의 요인에 의해 촉진되고 있습니다. 의료비 지출의 증가는 면역성 혈소판 감소성 자반증(ITP)과 같은 만성 질환 치료를 위한 로미플로스티움과 같은 고급 생물학적 제제의 접근성을 높입니다. 예를 들어, 2024년 5월, 영국 국가통계청(Office for National Statistics)은 2022년부터 2023년까지 영국 전체 의료비 지출이 5.6% 증가했다고 발표하여, Romiplostim과 관련된 의료 서비스를 포함한 의료 서비스에 대한 투자가 증가할 것으로 전망했습니다. 이러한 동향은 Nplate 및 로미플레이트(로미플로스팀) 시장의 성장을 뒷받침할 것입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 바이오의약품 시장에서의 제품 특성

• 분자 유형
• 투여경로(ROA)
• 작용기전(MOA)
• 안전성과 유효성

제4장 시장 동향과 전략

제5장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염, 경기 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제6장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 Nplate 및 로미플레이트(로미플로스팀) : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업의 분석
• 세계의 Nplate 및 로미플레이트(로미플로스팀) 시장 : 성장률 분석
• 세계의 Nplate 및 로미플레이트(로미플로스팀) 시장 실적 : 규모와 성장(2019-2024년)
• 세계의 Nplate 및 로미플레이트(로미플로스팀) 시장 예측 : 규모와 성장(2024-2029년, 2034년)
• 세계의 Nplate 및 로미플레이트(로미플로스팀) : 전체 시장 규모(TAM)

제7장 세계 시장의 가격 분석과 예측

제8장 시장 세분화

• 세계의 Nplate 및 로미플레이트(로미플로스팀) 시장 : 환자 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 소아
• 성인
• 노인
• 세계의 Nplate 및 로미플레이트(로미플로스팀) 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 만성 면역 혈소판 감소증
• 화학요법 유발성 혈소판 감소증
• 기타
• 세계의 Nplate 및 로미플레이트(로미플로스팀) 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 병원 약국
• 소매 약국
• 온라인 약국

제9장 임상적응증 세계 시장 역학

• 약제의 부작용
• 임상적응증의 발병률과 유병률

제10장 지역별, 국가별 분석

• 세계의 Nplate 및 로미플레이트(로미플로스팀) 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 세계의 Nplate 및 로미플레이트(로미플로스팀) 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 한국 시장

제17장 서유럽 시장

제18장 영국 시장

제19장 독일 시장

제20장 프랑스 시장

제21장 동유럽 시장

제22장 북미 시장

제23장 미국 시장

제24장 캐나다 시장

제25장 남미 시장

제26장 중동 시장

제27장 아프리카 시장

제28장 경쟁 구도와 기업 프로파일

• Nplate 및 로미플레이트(로미플로스팀) 시장 : 경쟁 구도
• Nplate 및 로미플레이트(로미플로스팀) 시장 : 기업 프로파일
  • Novartis AG
  • Amgen
  • Intas Pharmaceuticals

제29장 세계 시장 : 파이프라인 분석

제30장 세계 시장 경쟁 벤치마킹과 대시보드

제31장 주요 인수합병(M&A)

제32장 최근 시장 동향

제33장 시장의 잠재력이 높은 국가, 전략

• Nplate 및 로미플레이트(로미플로스팀) 시장(2029년) : 새로운 기회를 제공하는 국가
• Nplate 및 로미플레이트(로미플로스팀) 시장(2029년) : 새로운 기회를 제공하는 부문
• Nplate 및 로미플레이트(로미플로스팀) 시장(2029년) : 성장 전략
  • 시장 동향에 의한 전략
  • 경쟁 전략

제34장 부록

HBR

영문 목차

영문목차

Nplate and Romiplate (romiplostim) are biologic drugs classified as thrombopoietin receptor agonists, used to treat immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, increasing the risk of bleeding. Romiplostim stimulates platelet production in the bone marrow, helping maintain a safe platelet count in patients with chronic ITP.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary patient groups for nplate and romiplate (romiplostim) include pediatric, adult, and geriatric patients. This includes children and adolescents diagnosed with conditions such as chronic immune thrombocytopenia (ITP) that require Romiplate treatment. Romiplate stimulates platelet production, making it a crucial therapy for younger patients with low platelet counts. Pediatric patients may need specific dosages and close monitoring due to their developing bodies. It is used for various conditions, including chronic immune thrombocytopenia, chemotherapy-induced thrombocytopenia, and others, and is available through hospital, retail, and online pharmacies.

The nplate, romiplate (romiplostim) market research report is one of a series of new reports from The Business Research Company that provides nplate, romiplate (romiplostim) market statistics, including the nplate, romiplate (romiplostim) industry's global market size, regional shares, competitors with a nplate, romiplate (romiplostim) market share, detailed nplate, romiplate (romiplostim) market segments, market trends and opportunities, and any further data you may need to thrive in the nplate, romiplate (romiplostim) industry. This nplate, romiplate (romiplostim) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The nplate, romiplate (romiplostim) market size is expected to see strong growth in the next few years. It will grow to $1,871.5 million in 2029 at a compound annual growth rate (CAGR) of 9%. The growth in the forecast period can be attributed to increasing global healthcare access, growing health economics, increasing biotechnology innovations, growing effective treatments, and increasing blood disorders. Major trends in the forecast period include emerging biosimilars, advancements in treatment protocols, technology integration, drug delivery approach, strategic collaborations, and investments in research and developments.

The increasing incidence of cancer is expected to propel the growth of the nplate, romiplate (romiplostim) market. Cancer refers to a group of diseases characterized by the abnormal and uncontrolled growth of cells. The rise in cancer cases is attributed to factors such as an aging population, environmental exposure to carcinogens, unhealthy lifestyle choices (e.g., smoking, poor diet), genetic factors, and advancements in diagnostic techniques that lead to earlier and more frequent cancer detection. Nplate and Romiplate (Romiplostim) stimulate platelet production via the thrombopoietin receptor, which helps cancer patients-especially those undergoing chemotherapy-by reducing the risk of thrombocytopenia (low platelet counts), improving platelet levels, enhancing safety during treatment, and minimizing the need for platelet transfusions. For example, in August 2024, the Australian Institute of Health and Welfare projected that by 2034, Australia would see approximately 209,000 new cancer diagnoses, up from an estimated 169,000 in 2024, reflecting the impact of a growing population and increasing cancer rates. Thus, the rising cancer incidence will drive the nplate, romiplate (romiplostim) market.

Rising healthcare expenditure is expected to propel the growth of the nplate, romiplate (romiplostim) market. Healthcare expenditure refers to the total spending on healthcare goods and services, including personal health care, preventive services, and public health activities aimed at improving health outcomes. The rise in healthcare expenditure is driven by factors such as an aging population, chronic diseases, technological advancements in healthcare, high drug prices, and increased service demand. Rising healthcare expenditure boosts access to advanced biologics like Romiplostim for treating chronic conditions such as Immune Thrombocytopenic Purpura (ITP). For instance, in May 2024, the Office for National Statistics reported a 5.6% increase in total healthcare expenditure in the UK from 2022 to 2023, signaling greater investment in healthcare services, including those related to Romiplostim. This trend will support the growth of the nplate, romiplate (romiplostim) market.

A key trend in the nplate, romiplate (romiplostim) market is the development of Nplate for FDA approval to protect adults and children exposed to acute myelosuppressive doses of radiation. Nplate is now being developed for use in radiological or nuclear emergencies, with an administration kit designed to simplify its delivery. For instance, in October 2023, the Biomedical Advanced Research and Development Authority (BARDA) announced support for the development of the Nplate administration kit. This kit aims to simplify the use of Nplate during radiological or nuclear emergencies, with BARDA procuring additional doses of Nplate as part of Project BioShield. Nplate is approved to increase survival rates in both adult and pediatric patients (including newborns) exposed to myelosuppressive doses of radiation, specifically in cases of Hematopoietic Syndrome of Acute Radiation Syndrome (HSARS). This trend is part of the U.S. government's efforts to enhance preparedness for radiological and nuclear emergencies, which is expected to drive the Nplate, Romiplate (Romiplostim) market.

Major players operating in the nplate, romiplate (romiplostim) market are Novartis AG, Amgen, Intas Pharmaceuticals.

North America was the largest region in the nplate, romiplate (romiplostim) market in 2024. The regions covered in nplate, romiplate (romiplostim) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the nplate, romiplate (romiplostim) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The nplate, romiplate (romiplostim) market consists of sales of the lyophilized powder for injection, nplate 500 mcg, and nplate 125 mcg. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Nplate, Romiplate (romiplostim) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on nplate, romiplate (romiplostim) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for nplate, romiplate (romiplostim) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The nplate, romiplate (romiplostim) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Patient Type: Pediatric Patients; Adult Patients; Geriatric Patients
• 2) By Application: Chronic Immune Thrombocytopenia; Chemotherapy-Induced Thrombocytopenia; Other Applications
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• Companies Mentioned: Novartis AG; Amgen; Intas Pharmaceuticals
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Nplate, Romiplate (Romiplostim) Market Characteristics

3. Nplate, Romiplate (Romiplostim) Market Biologic Drug Characteristics

• 3.1. Molecule Type
• 3.2. Route Of Administration (ROA)
• 3.3. Mechanism Of Action (MOA)
• 3.4. Safety And Efficacy

4. Nplate, Romiplate (Romiplostim) Market Trends And Strategies

5. Nplate, Romiplate (Romiplostim) Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

6. Global Nplate, Romiplate (Romiplostim) Growth Analysis And Strategic Analysis Framework

• 6.1. Global Nplate, Romiplate (Romiplostim) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 6.2. Analysis Of End Use Industries
• 6.3. Global Nplate, Romiplate (Romiplostim) Market Growth Rate Analysis
• 6.4. Global Nplate, Romiplate (Romiplostim) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 6.5. Global Nplate, Romiplate (Romiplostim) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 6.6. Global Nplate, Romiplate (Romiplostim) Total Addressable Market (TAM)

7. Global Nplate, Romiplate (Romiplostim) Market Pricing Analysis & Forecasts

8. Nplate, Romiplate (Romiplostim) Market Segmentation

• 8.1. Global Nplate, Romiplate (Romiplostim) Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pediatric Patients
• Adult Patients
• Geriatric Patients
• 8.2. Global Nplate, Romiplate (Romiplostim) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chronic Immune Thrombocytopenia
• Chemotherapy-Induced Thrombocytopenia
• Other Applications
• 8.3. Global Nplate, Romiplate (Romiplostim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

9. Global Nplate, Romiplate (Romiplostim) Market Epidemiology Of Clinical Indications

• 9.1. Drug Side Effects
• 9.2. Incidence And Prevalence of Clinical Indications

10. Nplate, Romiplate (Romiplostim) Market Regional And Country Analysis

• 10.1. Global Nplate, Romiplate (Romiplostim) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. Global Nplate, Romiplate (Romiplostim) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Asia-Pacific Nplate, Romiplate (Romiplostim) Market

• 11.1. Asia-Pacific Nplate, Romiplate (Romiplostim) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Nplate, Romiplate (Romiplostim) Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Asia-Pacific Nplate, Romiplate (Romiplostim) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Asia-Pacific Nplate, Romiplate (Romiplostim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. China Nplate, Romiplate (Romiplostim) Market

• 12.1. China Nplate, Romiplate (Romiplostim) Market Overview
• 12.2. China Nplate, Romiplate (Romiplostim) Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.3. China Nplate, Romiplate (Romiplostim) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.4. China Nplate, Romiplate (Romiplostim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

13. India Nplate, Romiplate (Romiplostim) Market

• 13.1. India Nplate, Romiplate (Romiplostim) Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. India Nplate, Romiplate (Romiplostim) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. India Nplate, Romiplate (Romiplostim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. Japan Nplate, Romiplate (Romiplostim) Market

• 14.1. Japan Nplate, Romiplate (Romiplostim) Market Overview
• 14.2. Japan Nplate, Romiplate (Romiplostim) Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. Japan Nplate, Romiplate (Romiplostim) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. Japan Nplate, Romiplate (Romiplostim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Australia Nplate, Romiplate (Romiplostim) Market

• 15.1. Australia Nplate, Romiplate (Romiplostim) Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.2. Australia Nplate, Romiplate (Romiplostim) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Australia Nplate, Romiplate (Romiplostim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. South Korea Nplate, Romiplate (Romiplostim) Market

• 16.1. South Korea Nplate, Romiplate (Romiplostim) Market Overview
• 16.2. South Korea Nplate, Romiplate (Romiplostim) Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. South Korea Nplate, Romiplate (Romiplostim) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.4. South Korea Nplate, Romiplate (Romiplostim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Western Europe Nplate, Romiplate (Romiplostim) Market

• 17.1. Western Europe Nplate, Romiplate (Romiplostim) Market Overview
• 17.2. Western Europe Nplate, Romiplate (Romiplostim) Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Western Europe Nplate, Romiplate (Romiplostim) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.4. Western Europe Nplate, Romiplate (Romiplostim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. UK Nplate, Romiplate (Romiplostim) Market

• 18.1. UK Nplate, Romiplate (Romiplostim) Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. UK Nplate, Romiplate (Romiplostim) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. UK Nplate, Romiplate (Romiplostim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Germany Nplate, Romiplate (Romiplostim) Market

• 19.1. Germany Nplate, Romiplate (Romiplostim) Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Germany Nplate, Romiplate (Romiplostim) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Germany Nplate, Romiplate (Romiplostim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. France Nplate, Romiplate (Romiplostim) Market

• 20.1. France Nplate, Romiplate (Romiplostim) Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. France Nplate, Romiplate (Romiplostim) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. France Nplate, Romiplate (Romiplostim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Nplate, Romiplate (Romiplostim) Market

• 21.1. Eastern Europe Nplate, Romiplate (Romiplostim) Market Overview
• 21.2. Eastern Europe Nplate, Romiplate (Romiplostim) Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Nplate, Romiplate (Romiplostim) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Nplate, Romiplate (Romiplostim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. North America Nplate, Romiplate (Romiplostim) Market

• 22.1. North America Nplate, Romiplate (Romiplostim) Market Overview
• 22.2. North America Nplate, Romiplate (Romiplostim) Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. North America Nplate, Romiplate (Romiplostim) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.4. North America Nplate, Romiplate (Romiplostim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. USA Nplate, Romiplate (Romiplostim) Market

• 23.1. USA Nplate, Romiplate (Romiplostim) Market Overview
• 23.2. USA Nplate, Romiplate (Romiplostim) Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. USA Nplate, Romiplate (Romiplostim) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. USA Nplate, Romiplate (Romiplostim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. Canada Nplate, Romiplate (Romiplostim) Market

• 24.1. Canada Nplate, Romiplate (Romiplostim) Market Overview
• 24.2. Canada Nplate, Romiplate (Romiplostim) Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. Canada Nplate, Romiplate (Romiplostim) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. Canada Nplate, Romiplate (Romiplostim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. South America Nplate, Romiplate (Romiplostim) Market

• 25.1. South America Nplate, Romiplate (Romiplostim) Market Overview
• 25.2. South America Nplate, Romiplate (Romiplostim) Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. South America Nplate, Romiplate (Romiplostim) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. South America Nplate, Romiplate (Romiplostim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. Middle East Nplate, Romiplate (Romiplostim) Market

• 26.1. Middle East Nplate, Romiplate (Romiplostim) Market Overview
• 26.2. Middle East Nplate, Romiplate (Romiplostim) Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. Middle East Nplate, Romiplate (Romiplostim) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. Middle East Nplate, Romiplate (Romiplostim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Africa Nplate, Romiplate (Romiplostim) Market

• 27.1. Africa Nplate, Romiplate (Romiplostim) Market Overview
• 27.2. Africa Nplate, Romiplate (Romiplostim) Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Africa Nplate, Romiplate (Romiplostim) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.4. Africa Nplate, Romiplate (Romiplostim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Nplate, Romiplate (Romiplostim) Market Competitive Landscape And Company Profiles

• 28.1. Nplate, Romiplate (Romiplostim) Market Competitive Landscape
• 28.2. Nplate, Romiplate (Romiplostim) Market Company Profiles
  • 28.2.1. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 28.2.2. Amgen Overview, Products and Services, Strategy and Financial Analysis
  • 28.2.3. Intas Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis

29. Global Nplate, Romiplate (Romiplostim) Market Pipeline Analysis

• 29.1. High Level Clinic Trail Information

30. Global Nplate, Romiplate (Romiplostim) Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Nplate, Romiplate (Romiplostim) Market

32. Recent Developments In The Nplate, Romiplate (Romiplostim) Market

33. Nplate, Romiplate (Romiplostim) Market High Potential Countries, Segments and Strategies

• 33.1 Nplate, Romiplate (Romiplostim) Market In 2029 - Countries Offering Most New Opportunities
• 33.2 Nplate, Romiplate (Romiplostim) Market In 2029 - Segments Offering Most New Opportunities
• 33.3 Nplate, Romiplate (Romiplostim) Market In 2029 - Growth Strategies
  • 33.3.1 Market Trend Based Strategies
  • 33.3.2 Competitor Strategies

34. Appendix

• 34.1. Abbreviations
• 34.2. Currencies
• 34.3. Historic And Forecast Inflation Rates
• 34.4. Research Inquiries
• 34.5. The Business Research Company
• 34.6. Copyright And Disclaimer

관련자료